RECORD // Company
Q/C Technologies, Inc.
Formerly: Q/C TECHNOLOGIES, INC.; TNF Pharmaceuticals, Inc.; MyMD Pharmaceuticals, Inc.; Akers Biosciences, Inc.; Akers Biosciences Inc
Built 2026-11-22T01:48:01Z from public sources · JSON · Open the company profile
ASK THE RECORDS
Ask
COMPANY
Records for this company (2 joined by official identifier)
Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.
Gleif lei (1)
- Q/C TECHNOLOGIES, INC. · legal entity in this company's GLEIF ownership tree (LEI 213800CSKAC96ELS4K25)
SEC EDGAR (1)
- Q/C TECHNOLOGIES, INC. · the SEC registrant record of this company
Records under a former name (3)
The name on these records was this company's name in the past (SEC name history). An old name can also belong to an unrelated organization, so they are shown apart and are not counted above.
- TNF Pharmaceuticals, Inc. · Ctgov
- AKERS BIOSCIENCES, INC. · East licences
- AKERS BIOSCIENCES INC · Epa echo
2 VALUES · 10-Q · EACH LINKS TO ITS FILING
Latest quarter
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-16 · accession 0001493152-26-052072
| Item | Value | Period | Form | Filed | Accession | Report | |
|---|---|---|---|---|---|---|---|
| Net income (loss) | $-941,793 | 3 months ended 2026-09-30 | 10-Q | 2026-11-16 | 0001493152-26-052072 | 2026-11-22 01:48 UTC | Report an error |
| Cash and cash equivalents | $2,585,051 | at 2026-09-30 | 10-Q | 2026-11-16 | 0001493152-26-052072 | 2026-11-22 01:48 UTC | Report an error |
Negative as reported in the filing.
Not in this report's XBRL: Revenue, Interest expense.
Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.
IDS
Identifiers
- SEC CIK
- 0001321834
- Ticker
- QCLS
- CUSIP
- 62856X300
- Record ID
- sx:sec:0001321834
OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA
Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
28 FACTS · EACH LINKS TO ITS FILING
Facts
| Fact | Value | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-20 | SEC EDGAR company profile | 2026-11-22 01:48 UTC | Report an error |
| SIC industry | 2835 In Vitro & In Vivo Diagnostic Substances | 2026-11-20 | SEC EDGAR company profile | 2026-11-22 01:48 UTC | Report an error |
| State of incorporation | DE | 2026-11-20 | SEC EDGAR company profile | 2026-11-22 01:48 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-20 | SEC EDGAR company profile | 2026-11-22 01:48 UTC | Report an error |
| Business address | 1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036 | 2026-11-20 | SEC EDGAR company profile | 2026-11-22 01:48 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-20 | SEC EDGAR company profile | 2026-11-22 01:48 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | $-11,627,122 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | 2026-11-22 01:48 UTC | Report an error |
| Total assets (at 2025-12-31) | $41,166,096 | 2025-12-31 | 10-K, XBRL Assets | 2026-11-22 01:48 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $21,751,675 | 2025-12-31 | 10-K, XBRL StockholdersEquity | 2026-11-22 01:48 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $986,996 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | 2026-11-22 01:48 UTC | Report an error |
| Operating cash flow (fiscal year ended 2025-12-31) | $-9,065,619 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | 2026-11-22 01:48 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $1,750,000 | 2025-12-31 | 10-K, XBRL PaymentsToAcquireProductiveAssets | 2026-11-22 01:48 UTC | Report an error |
| Operating lease liabilities (at 2024-12-31) | $10,579 | 2024-12-31 | 10-K, XBRL OperatingLeaseLiability | 2026-11-22 01:48 UTC | Report an error |
| Form D total offering amount (D filed 2025-09-05) | $7,000,000 | 2025-09-05 | D | 2026-11-22 01:48 UTC | Report an error |
| Form D total amount sold (D filed 2025-09-05) | $7,000,000 | 2025-09-05 | D | 2026-11-22 01:48 UTC | Report an error |
| Form D industry group | Pharmaceuticals | 2025-09-05 | D | 2026-11-22 01:48 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2025-09-05 | D | 2026-11-22 01:48 UTC | Report an error |
| Form D date of first sale | 2025-09-02 | 2025-09-05 | D | 2026-11-22 01:48 UTC | Report an error |
| Largest institutional holder #1 (13F as filed): Quinn Opportunity Partners LLC | $479,794 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 01:48 UTC | Report an error |
| Largest institutional holder #2 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC | $448,621 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 01:48 UTC | Report an error |
| Largest institutional holder #3 (13F as filed): JANE STREET GROUP, LLC | $340,240 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 01:48 UTC | Report an error |
| Largest institutional holder #4 (13F as filed): GEODE CAPITAL MANAGEMENT, LLC | $275,659 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 01:48 UTC | Report an error |
| Largest institutional holder #5 (13F as filed): UBS Group AG | $229,686 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 01:48 UTC | Report an error |
| Largest institutional holder #6 (13F as filed): Balyasny Asset Management L.P. | $224,999 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 01:48 UTC | Report an error |
| Largest institutional holder #7 (13F as filed): ADAR1 Capital Management, LLC | $195,000 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 01:48 UTC | Report an error |
| Largest institutional holder #8 (13F as filed): VANGUARD FIDUCIARY TRUST CO | $167,907 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 01:48 UTC | Report an error |
| Largest institutional holder #9 (13F as filed): STATE STREET CORP | $98,690 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 01:48 UTC | Report an error |
| Largest institutional holder #10 (13F as filed): DIMENSIONAL FUND ADVISORS LP | $74,326 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 01:48 UTC | Report an error |
EVERY DATED RECORD, NEWEST FIRST
Timeline
- 2026-11-20 Filing 8-K filed: Item 1.01 material agreement; Item 3.03 rights of holders modified; Item 9.01 exhibits
- 2026-11-16 Filing 10-Q filed
- 2026-11-13 Filing 8-K filed: Item 3.01 delisting notice
- 2026-09-18 Filing 8-K filed: Item 1.01 material agreement; Item 5.02 officer or director change; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-09-11 Filing 8-K filed: Item 1.02 agreement terminated; Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-08-12 Filing 10-Q filed
- 2026-07-02 Filing 8-K filed: Item 1.02 agreement terminated; Item 8.01 other event
- 2026-05-15 Filing 10-Q filed
- 2026-04-29 Filing 10-K/A filed
- 2026-04-15 Filing 10-K filed
- 2026-03-31 Filing NT 10-K filed
- 2026-03-13 Filing 8-K filed: Item 4.01 auditor change; Item 9.01 exhibits
- 2026-02-17 Filing EFFECT filed
- 2026-02-12 Filing CORRESP filed
- 2026-02-11 Filing S-3 filed
- 2026-01-28 Filing UPLOAD filed
- 2026-01-23 Filing 8-K filed: Item 1.01 material agreement; Item 5.02 officer or director change; Item 8.01 other event; Item 9.01 exhibits
- 2026-01-23 Filing DRS filed
- 2025-12-09 Filing 8-K filed: Item 1.01 material agreement; Item 3.02 unregistered equity sale; Item 8.01 other event; Item 9.01 exhibits
- 2025-12-01 Filing 424B3 filed
- 2025-11-28 Filing EFFECT filed
- 2025-11-25 Filing CORRESP filed
- 2025-11-19 Filing 10-Q filed
- 2025-11-14 Filing NT 10-Q filed
- 2025-11-14 Filing 8-K filed: Item 5.02 officer or director change; Item 5.07 shareholder vote; Item 9.01 exhibits
WHAT IS NOT HERE
Gaps
- Court records: not covered yet (expected 11-19).
- No EIN on the SEC filing, so no Form 990 lookup
- USAspending: no recipient whose SAM legal name and address match this SEC filer
SOURCES AND LICENSE
Sources
- SEC EDGAR: checked · 2026-11-22T01:48:02Z
- Propublica 990: checked, nothing found · 2026-11-22T01:48:02Z
- SEC 13F holdings: checked · 2026-11-22T01:48:03Z
- USAspending: checked, nothing found · 2026-11-22T01:48:08Z
CC BY 4.0 -- credit Seraphix Systems.
API
Use this record
Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.